tiprankstipranks
NervGen Pharma (TSE:NGEN)
:NGEN
Canadian Market

NervGen Pharma (NGEN) Cash flow

Compare
35 Followers

NervGen Pharma Cash Flow

TSE:NGEN's free cash flow for Q3 2024 was C$-5.75M. For the 2024 fiscal year, TSE:NGEN's free cash flow was decreased by C$6.37M and operating cash flow was C$-5.75M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
C$ -11.30MC$ -17.78MC$ -8.27MC$ -6.31MC$ -8.09M
Investing Cash Flow
C$ -138.85KC$ -21.11KC$ -45.09KC$ -3.42KC$ 0.00
Financing Cash Flow
C$ 766.28KC$ 22.64MC$ 19.61MC$ 7.85MC$ 9.84M
End Cash Position
C$ 11.66MC$ 22.45MC$ 16.93MC$ 5.60MC$ 4.11M
Free Cash Flow
C$ -11.44MC$ -17.81MC$ -8.31MC$ -6.31MC$ -8.09M
Currency in CAD

NervGen Pharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis